| Samuel M Nyamu, MD | |
|
11333 N Sepulveda Blvd, Mission Hills, CA 91345-1116 | |
| (818) 869-7248 | |
| (818) 869-2709 |
| Full Name | Samuel M Nyamu |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 24 Years |
| Location | 11333 N Sepulveda Blvd, Mission Hills, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023268869 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Facey Medical Foundation | 3173436276 | 282 |
News Archive
Prostate cancer, the second leading cause of cancer death for men in the United States, is caused by changes in several tummor suppressor genes including PTEN and p53. Up to 70 percent of men with prostate cancer have lost one copy of the PTEN gene at the time of diagnosis, and p53 is absent in a high number of patients with advanced prostate cancer.
Some of the greatest wonders of the 21st century will probably occur on a small scale – in fact a tiny scale – smaller than a human blood cell, right down there at the level of atoms and molecules.
The use of at-home medical devices to connect doctors and patients via the Internet can help patients and their physicians work more efficiently together to manage chronic conditions, according to research at Cleveland Clinic.
The purported "game-changer" anti-malarial drug Hydroxychloroquine, which was claimed to be effective in preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and also helping better outcomes in COVID-19 patients, seems to have failed in clinical trials.
› Verified 3 days ago
| Entity Name | Providence Facey Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710031588 PECOS PAC ID: 3173436276 Enrollment ID: O20031105000822 |
News Archive
Prostate cancer, the second leading cause of cancer death for men in the United States, is caused by changes in several tummor suppressor genes including PTEN and p53. Up to 70 percent of men with prostate cancer have lost one copy of the PTEN gene at the time of diagnosis, and p53 is absent in a high number of patients with advanced prostate cancer.
Some of the greatest wonders of the 21st century will probably occur on a small scale – in fact a tiny scale – smaller than a human blood cell, right down there at the level of atoms and molecules.
The use of at-home medical devices to connect doctors and patients via the Internet can help patients and their physicians work more efficiently together to manage chronic conditions, according to research at Cleveland Clinic.
The purported "game-changer" anti-malarial drug Hydroxychloroquine, which was claimed to be effective in preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and also helping better outcomes in COVID-19 patients, seems to have failed in clinical trials.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Samuel M Nyamu, MD Po Box 9602, Mission Hills, CA 91346-9602 Ph: (818) 837-5559 | Samuel M Nyamu, MD 11333 N Sepulveda Blvd, Mission Hills, CA 91345-1116 Ph: (818) 869-7248 |
News Archive
Prostate cancer, the second leading cause of cancer death for men in the United States, is caused by changes in several tummor suppressor genes including PTEN and p53. Up to 70 percent of men with prostate cancer have lost one copy of the PTEN gene at the time of diagnosis, and p53 is absent in a high number of patients with advanced prostate cancer.
Some of the greatest wonders of the 21st century will probably occur on a small scale – in fact a tiny scale – smaller than a human blood cell, right down there at the level of atoms and molecules.
The use of at-home medical devices to connect doctors and patients via the Internet can help patients and their physicians work more efficiently together to manage chronic conditions, according to research at Cleveland Clinic.
The purported "game-changer" anti-malarial drug Hydroxychloroquine, which was claimed to be effective in preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and also helping better outcomes in COVID-19 patients, seems to have failed in clinical trials.
› Verified 3 days ago
Armin Tahoori, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 11333 Sepulveda Blvd, Mission Hills, CA 91345 Phone: 818-365-9531 | |
Hayka Hovsepyan, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 14901 Rinaldi St Ste 200, Mission Hills, CA 91345 Phone: 818-365-8553 Fax: 818-365-5763 | |
Dr. Donald Rebhun, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 11600 Indian Hills Rd, Mission Hills, CA 91345 Phone: 818-838-4510 Fax: 818-838-7510 | |
Pascal Dabel, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 11550 Indian Hills Rd Ste 371, Mission Hills, CA 91345 Phone: 818-365-1194 Fax: 818-898-3835 | |
Dr. Carmen S Slavov, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 14901 Rinaldi St, Ste 200, Mission Hills, CA 91345 Phone: 818-254-1500 Fax: 818-244-4830 | |
Mohammad Reza Nahed, MD FCCP Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 11550 Indian Hills Rd, 301, Mission Hills, CA 91345 Phone: 818-365-4585 Fax: 818-365-5265 |